STOCK TITAN
  1. Home
  2. NLTX

NLTX (NLTX) Stock Price, News & Analysis

NLTX

Company Description

This page collects what Stock Titan holds for NLTX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Latest News

View All
+1.62%

Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split

stock split
-1.63%

Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split

stock split
-20.11%

Neurogene and Neoleukin Announce Definitive Merger Agreement

acquisition
+35.80%

Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition

management
+7.12%

Neoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual Meeting

clinical trial
-19.86%

Neoleukin Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Update

earnings

NLTX has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include stock split, acquisition, management, clinical trial, earnings. View all NLTX news →

SEC Filings

View All

No SEC filings available for NLTX.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months